The Cooper Companies, Inc. (COO)

US — Healthcare Sector
Peers: WST  HOLX  ICUI  HAE  TFX  RMD  BDX  BLCO  RGEN  MMSI  ANGO  ATR  NVST 

Automate Your Wheel Strategy on COO

With Tiblio's Option Bot, you can configure your own wheel strategy including COO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol COO
  • Rev/Share 19.951
  • Book/Share 41.4612
  • PB 1.6585
  • Debt/Equity 0.3119
  • CurrentRatio 2.0995
  • ROIC 0.0435

 

  • MktCap 13718445120.0
  • FreeCF/Share 1.8304
  • PFCF 37.4923
  • PE 33.1848
  • Debt/Assets 0.2083
  • DivYield 0
  • ROE 0.0511

 

  • Rating B
  • Score 3
  • Recommendation Neutral
  • P/E Score 1
  • DCF Score 4
  • P/B Score 3
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Upgrade COO Needham Hold Buy -- $94 June 17, 2025
Downgrade COO JP Morgan Overweight Neutral -- $76 May 30, 2025
Reiterated COO Piper Sandler -- Overweight $115 $120 Aug. 29, 2024

News

Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term
COO
Published: June 03, 2025 by: Zacks Investment Research
Sentiment: Positive

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read More
image for news Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term
Understanding The Cooper Companies (COO) Reliance on International Revenue
COO
Published: June 02, 2025 by: Zacks Investment Research
Sentiment: Neutral

Explore The Cooper Companies' (COO) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Read More
image for news Understanding The Cooper Companies (COO) Reliance on International Revenue
COO Q2 Earnings Signal Growth and Caution: How to Play the Stock?
COO
Published: June 02, 2025 by: Zacks Investment Research
Sentiment: Neutral

Cooper Companies COO delivered a solid fiscal second quarter performance in 2025, surpassing analyst expectations with $1 billion in revenue (up 6.3% YoY) and adjusted earnings per share (EPS) of 96 cents (up 14% YoY). Despite persistent macroeconomic headwinds and a slightly softened outlook for industry growth, management reaffirmed confidence in its core product momentum and operational leverage.

Read More
image for news COO Q2 Earnings Signal Growth and Caution: How to Play the Stock?
XRAY vs. COO: Which Stock Should Value Investors Buy Now?
COO, XRAY
Published: May 30, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or The Cooper Companies (COO). But which of these two stocks offers value investors a better bang for their buck right now?

Read More
image for news XRAY vs. COO: Which Stock Should Value Investors Buy Now?
COO Q2 Earnings Beat, 2025 Sales Outlook Tightened, Stock Down
COO
Published: May 30, 2025 by: Zacks Investment Research
Sentiment: Positive

COO's fiscal Q2 earnings and sales beat market expectations on the back of strong growth. Improvement in operating margin bodes well.

Read More
image for news COO Q2 Earnings Beat, 2025 Sales Outlook Tightened, Stock Down
The Cooper Companies, Inc. (COO) Q2 2025 Earnings Call Transcript
COO
Published: May 29, 2025 by: Seeking Alpha
Sentiment: Neutral

The Cooper Companies, Inc. (NASDAQ:COO ) Q2 2025 Results Conference Call May 29, 2025 5:00 PM ET Company Participants Kim Duncan - Vice President, Investor Relations & Risk Management Al White - President & Chief Executive Officer Brian Andrews - Chief Financial Officer & Treasurer Conference Call Participants Jeff Johnson - Baird Issie Kirby - Redburn Atlantic Larry Biegelsen - Wells Fargo Jon Block - Stifel Robbie Marcus - JPMorgan Craig Bijou - Bank of America Joanne Wuensch - Citi Young Li - Jefferies Chris Pasquale - Nephron Research Jason Badner - Piper Sandler Brett Fishbin - KeyBanc Steve Lichtman …

Read More
image for news The Cooper Companies, Inc. (COO) Q2 2025 Earnings Call Transcript
The Cooper Companies (COO) Reports Q2 Earnings: What Key Metrics Have to Say
COO
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Positive

Although the revenue and EPS for The Cooper Companies (COO) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Read More
image for news The Cooper Companies (COO) Reports Q2 Earnings: What Key Metrics Have to Say
The Cooper Companies (COO) Surpasses Q2 Earnings and Revenue Estimates
COO
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Positive

The Cooper Companies (COO) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $0.85 per share a year ago.

Read More
image for news The Cooper Companies (COO) Surpasses Q2 Earnings and Revenue Estimates
Reasons to Retain The Cooper Companies Stock in Your Portfolio Now
COO
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Positive

COO benefits from the strength in its business segments. Its acquisitions are likely to drive the top line.

Read More
image for news Reasons to Retain The Cooper Companies Stock in Your Portfolio Now
Insights Into The Cooper Companies (COO) Q2: Wall Street Projections for Key Metrics
COO
Published: May 23, 2025 by: Zacks Investment Research
Sentiment: Neutral

Evaluate the expected performance of The Cooper Companies (COO) for the quarter ended April 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Read More
image for news Insights Into The Cooper Companies (COO) Q2: Wall Street Projections for Key Metrics
XRAY or COO: Which Is the Better Value Stock Right Now?
COO, XRAY
Published: May 14, 2025 by: Zacks Investment Research
Sentiment: Positive

Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Dentsply International (XRAY) and The Cooper Companies (COO). But which of these two stocks presents investors with the better value opportunity right now?

Read More
image for news XRAY or COO: Which Is the Better Value Stock Right Now?
Cooper Companies Q1 Earnings In Line, Revenues Miss, Stock Falls
COO
Published: March 07, 2025 by: Zacks Investment Research
Sentiment: Neutral

COO's top line fails to meet market expectations despite recording strong growth. However, improvement in operating margin bodes well.

Read More
image for news Cooper Companies Q1 Earnings In Line, Revenues Miss, Stock Falls
What Analyst Projections for Key Metrics Reveal About The Cooper Companies (COO) Q1 Earnings
COO
Published: March 03, 2025 by: Zacks Investment Research
Sentiment: Positive

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for The Cooper Companies (COO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended January 2025.

Read More
image for news What Analyst Projections for Key Metrics Reveal About The Cooper Companies (COO) Q1 Earnings

About The Cooper Companies, Inc. (COO)

  • IPO Date 1983-01-21
  • Website https://www.coopercos.com
  • Industry Medical - Instruments & Supplies
  • CEO Mr. Albert G. White III
  • Employees 16000

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.